SENNOSIDES tablet, film coated

Sennosides by

Drug Labeling and Warnings

Sennosides by is a Otc medication manufactured, distributed, or labeled by CVS Pharmacy, Inc. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Drug Facts

Active ingredient (in each tablet)
Sennosides 8.6 mg

PURPOSE

Purpose
Laxative

Uses

 relieves occasional constipation (irregularity)

 generally produces a bowel movement in 6-12 hours

WARNINGS

 laxative products for longer than 1 week unless directed by a doctor

Ask a doctor before use if you have

 stomach pain

 nausea

 vomiting
 noticed a sudden change in bowel habits that continues over a period of 2 weeks

Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

 take preferably at bedtime or as directed by a doctor

Age	starting dosage	maximum dosage
adults and children; 12 years of age and over	2 tablets once a day	4 tablets twice a day
children 6 to under 12 years	1 tablet once a day	2 tablets twice a day
children 2 to under 6 years	1/2 tablet once a day	1 tablet twice a day
children under 2 years	ask a doctor	ask a doctor

Other information

 each tablet contains: calcium 20 mg

 store in a dry place at 15° – 30°C (59° – 86°F)

INACTIVE INGREDIENT

croscarmellose sodium, dicalcium phosphate,hypromellose, magnesium stearate, maltodextrin, microcrystalline cellulose, mineral oil, polyethylene glycol, talc.

QUESTIONS

Call 1-800-231-4670 Monday - Friday 9AM-5PM EST

SPL UNCLASSIFIED SECTION

Distributed by:

CVS Pharmacy, Inc.
One CVS Drive
Woonsocket, RI 02895
© 2022 CVS/pharmacy
CVS.com® 1-800-SHOP CVS

TAMPER EVIDENT: DO NOT USE IF PRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING

KEEP THIS CARTON FOR COMPLETE WARNINGS AND PRODUCT INFORMATION

* This product is not manufactured or distributed by Avrio Health L.P., owner of the registered trademark Senokot®.

PRINCIPAL DISPLAY PANEL

Compare to the active ingredient in Senokot®*

Senna

SENNOSIDES, 8.6 mg
Laxative

Standardized senna concentrate
Natural vegetable laxative ingredient

50 TABLETS

Package Contains One Bottle

INGREDIENTS AND APPEARANCE

SENNOSIDES 
sennosides tablet, film coated

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 51316-112
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX)	SENNOSIDES	8.6 mg

Inactive Ingredients
Ingredient Name	Strength
HYPROMELLOSES (UNII: 3NXW29V3WO)
LIGHT MINERAL OIL (UNII: N6K5787QVP)
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE (UNII: O7TSZ97GEP)
MALTODEXTRIN (UNII: 7CVR7L4A2D)
TALC (UNII: 7SEV7J4R1U)
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)
MAGNESIUM STEARATE (UNII: 70097M6I30)

Product Characteristics
Color	brown	Score	no score
Shape	ROUND	Size	9mm
Flavor		Imprint Code	W2
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 51316-112-02	250 in 1 BOTTLE; Type 0: Not a Combination Product	03/23/2023
2	NDC: 51316-112-03	1 in 1 CARTON	07/26/2023
2		50 in 1 BOTTLE; Type 0: Not a Combination Product
3	NDC: 51316-112-05	500 in 1 BOTTLE; Type 0: Not a Combination Product	12/01/2023

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M007	03/23/2023

Labeler - CVS Pharmacy, Inc (062312574)